Clinical Trial Update: The Natural History of Procalcitonin in Hemorrhagic Stroke

View source ↗

Summary

A clinical trial investigating procalcitonin in hemorrhagic stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Stroke
• Intracerebral Hemorrhage
• Intraventricular Hemorrhage

Snippet

Sponsor: CAMC Health System | Conditions: Intraventricular Hemorrhage, Intracerebral Hemorrhage | Status: WITHDRAWN